Category Archives: regulatory

FDA Proactively Addresses Embryonic Stem Cell Safety Testing

Posted on December 31, 2007 by jrowley

The FDA has scheduled an April 10, 2008 meeting to “discuss scientific considerations for safety testing for cellular therapy products derived from human embryonic stem cells.” This meeting will be followed by another meeting on April 11 that will “discuss … Continue reading →

Advertisement

Posted in Advanced Cell Technology, cell delivery, Clinical Trials, Embyonic Stem Cells, FDA, Geron, Novocell, Regenerative Medicine, regulatory, stem cells | 1 Comment

Human-Animal Hybrids Prohibition Act Introduced in Congress

Posted on November 30, 2007 by jrowley

Senators Sam Brownback (R-Kan) and Mary Landrieu (D-La) introduced the Human-Animal Hybrid Prohibition Act to Congress last week that would make outlaws of scientists that create part human, part animal beings. According to a white paper published by Friends of … Continue reading →

Posted in ethics, politics, regulatory, stem cells | Leave a comment

Geron publishes data suggesting that Embyonic Stem Cells may not need long term immunosuppression

Posted on November 20, 2007 by jrowley

An interesting study was published this week in the Journal of Neuroimmunology spurring a press release from Geron that stated “GERON’S HUMAN EMBRYONIC STEM (ES) CELL-BASED THERAPEUTIC FOR SPINAL CORD INJURY EVADES DIRECT ATTACK BY THE HUMAN IMMUNE SYSTEM”. The … Continue reading →

Posted in Advanced Cell Technology, Clinical Trials, Embyonic Stem Cells, Geron, Regenerative Medicine, regulatory, spinal cord injury, stem cells | Tagged , , , | Leave a comment